AllSci has opened its Development Partner Program to R&D-driven life science organizations seeking to leverage the power of its revolutionary AI platform. This exclusive program offers early access to AllSci's proprietary pharmaceutical hypothesis database, advanced visualization engine, and AERIS—AllSci's cutting-edge AI purpose-built for research and scientific knowledge discovery.
Program partners will collaborate closely with AllSci to derive data-driven insights that inform their portfolio strategies, uncover R&D opportunities and gaps, and empower their researchers with tools to improve their efficiency, knowledge, and workflows.
"AllSci's technology transforms how pharmaceutical and biotech companies understand the R&D landscape, improves their research productivity, and helps them differentiate their portfolios and strategy" said Matthew Chervenak, Founder and CEO of AllSci.
Comments powered by CComment